Literature DB >> 23432626

Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization.

Amber L Bahorik1, Christina E Newhill, Shaun M Eack.   

Abstract

AIM: To characterize longitudinal patterns of substance use across a large sample of psychiatric patients discharged from inpatient admission, followed for 1-year post-hospitalization.
DESIGN: Prospective cohort study.
SETTING: Kansas City, MO, USA; Pittsburgh, PA, USA; Worcester, MA, USA. PARTICIPANTS: Eight hundred and one schizophrenia-spectrum (n = 204), bipolar (n = 137) and depressive disorder (n = 460) patients from the MacArthur Violence Risk Assessment Study. MEASUREMENTS: Symptoms, functioning, drug/alcohol use assessed by the Brief Psychiatric Rating Scale, the Global Assessment of Functioning, and substance use interviews.
FINDINGS: Patients used alcohol (67.0%; n = 540) and cannabis (30.0%; n = 237) more frequently than other substances up to 30 days before admission, and those with depressive and schizophrenia-spectrum used heroin more than individuals with bipolar (P = 0.023). Post-hospitalization, patients using alcohol (B = -0.15, P < 0.001) and cannabis (B = -0.27, P < 0.001) decreased, but patterns varied across diagnosis and genders. Patients using cannabis decreased at greater rates in depressive and schizophrenia-spectrum compared with bipolar (all P < 0.05), and more men used alcohol (B = 0.76, P < 0.001) and cannabis (B = 1.56, P < 0.001) than women. Cannabis (B = 1.65, P < 0.001) and alcohol (B = 1.04, P = 0.002) were associated with higher symptomatology; cannabis (B = -2.33, P < 0.001) and alcohol (B = -1.45, P = 0.012) were associated with lower functioning.
CONCLUSIONS: Substance use is frequent and associated with poor recovery in patients with serious mental illness recently discharged from psychiatric hospitalization. Addiction treatments personalized by diagnosis and gender may be effective for improving outcomes in people with serious mental illness.
© 2013 Society for the Study of Addiction.

Entities:  

Mesh:

Year:  2013        PMID: 23432626      PMCID: PMC3679358          DOI: 10.1111/add.12153

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  56 in total

Review 1.  The reality of comorbidity: depression and drug abuse.

Authors:  Nora D Volkow
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

2.  Does recovery from substance use disorder matter in patients with bipolar disorder?

Authors:  Roger D Weiss; Michael J Ostacher; Michael W Otto; Joseph R Calabrese; Mark Fossey; Stephen R Wisniewski; Charles L Bowden; Andrew A Nierenberg; Mark H Pollack; Ihsan M Salloum; Naomi M Simon; Michael E Thase; Gary S Sachs
Journal:  J Clin Psychiatry       Date:  2005-06       Impact factor: 4.384

Review 3.  Substance abuse treatment for people with schizophrenia.

Authors:  A S Bellack; J S Gearon
Journal:  Addict Behav       Date:  1998 Nov-Dec       Impact factor: 3.913

4.  The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization.

Authors:  R C Kessler; C B Nelson; K A McGonagle; M J Edlund; R G Frank; P J Leaf
Journal:  Am J Orthopsychiatry       Date:  1996-01

5.  Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders.

Authors:  Haiyi Xie; Gregory J McHugo; Barbara S Helmstetter; Robert E Drake
Journal:  Schizophr Res       Date:  2005-06-15       Impact factor: 4.939

Review 6.  Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes.

Authors:  L Dixon
Journal:  Schizophr Res       Date:  1999-03-01       Impact factor: 4.939

Review 7.  The epidemiology of dual diagnosis.

Authors:  Ronald C Kessler
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

Review 8.  Bipolar disorder and substance abuse.

Authors:  Frances R Levin; Grace Hennessy
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

9.  Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders.

Authors:  Robert E Drake; Haiyi Xie; Gregory J McHugo; Martha Shumway
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

Review 10.  Review of integrated mental health and substance abuse treatment for patients with dual disorders.

Authors:  R E Drake; C Mercer-McFadden; K T Mueser; G J McHugo; G R Bond
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

View more
  12 in total

1.  Is Capability to Manage Finances Stable Over Time?

Authors:  Christina M Lazar; Anne C Black; Marc I Rosen
Journal:  Am J Psychiatr Rehabil       Date:  2018 Fall-Winter

2.  Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial.

Authors:  Itxaso González-Ortega; Enrique Echeburúa; Susana Alberich; Miguel Bernardo; Eduard Vieta; Gonzalo Salazar de Pablo; Ana González-Pinto
Journal:  Int J Environ Res Public Health       Date:  2022-06-15       Impact factor: 4.614

3.  Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization.

Authors:  Amber L Bahorik; Stacy A Sterling; Cynthia I Campbell; Constance Weisner; Danielle Ramo; Derek D Satre
Journal:  J Affect Disord       Date:  2018-07-17       Impact factor: 4.839

4.  Adverse impact of marijuana use on clinical outcomes among psychiatry patients with depression and alcohol use disorder.

Authors:  Amber L Bahorik; Cynthia I Campbell; Stacy A Sterling; Amy Leibowitz; Adam Travis; Constance M Weisner; Derek D Satre
Journal:  Psychiatry Res       Date:  2017-10-19       Impact factor: 3.222

5.  Affective lability and social functioning in severe mental disorders.

Authors:  Margrethe Collier Høegh; Ingrid Melle; Sofie R Aminoff; Stine Holmstul Olsen; Synve Hoffart Lunding; Torill Ueland; Trine Vik Lagerberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-01-27       Impact factor: 5.760

6.  Social functioning trajectories of young first-episode psychosis patients with and without cannabis misuse: a 30-month follow-up study.

Authors:  César González-Blanch; John F Gleeson; Peter Koval; Sue M Cotton; Patrick D McGorry; Mario Alvarez-Jimenez
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

7.  Continued cannabis use at one year follow up is associated with elevated mood and lower global functioning in bipolar I disorder.

Authors:  Levi Roestad Kvitland; Ingrid Melle; Sofie Ragnhild Aminoff; Christine Demmo; Trine Vik Lagerberg; Ole Andreas Andreassen; Petter Andreas Ringen
Journal:  BMC Psychiatry       Date:  2015-02-05       Impact factor: 3.630

8.  Six-month outcome in bipolar spectrum alcoholics treated with acamprosate after detoxification: a retrospective study.

Authors:  Angelo Giovanni Icro Maremmani; Silvia Bacciardi; Luca Rovai; Fabio Rugani; Enrico Massimetti; Denise Gazzarrini; Liliana Dell'Osso; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2014-12-12       Impact factor: 3.390

9.  Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial.

Authors:  Itxaso González-Ortega; Enrique Echeburúa; Adriana García-Alocén; Patricia Vega; Ana González-Pinto
Journal:  Trials       Date:  2016-07-29       Impact factor: 2.279

10.  Factors associated with problematic drug use among psychiatric outpatients.

Authors:  Clarissa Mendonça Corradi-Webster; Edilaine Cristina da Silva Gherardi-Donato
Journal:  Rev Lat Am Enfermagem       Date:  2016-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.